Articles published by MyMD Pharmaceuticals, Inc.![]() ![]() ![]() ![]() Via Business Wire
Tickers
MYMD
![]()
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
December 06, 2023
Via Business Wire
Tickers
MYMD
![]() ![]() ![]() ![]() Via Business Wire
Tickers
MYMD
![]() ![]() ![]() ![]()
MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls
March 08, 2023
Via Business Wire
Tickers
MYMD
![]() ![]() ![]()
MyMD Announces $15 Million Offering with Existing Investors
February 21, 2023
Via Business Wire
Tickers
MYMD
![]() ![]() ![]() ![]() ![]()
MyMD Pharmaceuticals Receives Grant From European Patent Office for Supera-CBD™ Compound
August 30, 2022
Via Business Wire
Tickers
MYMD
![]() ![]() ![]() ![]() ![]() ![]() ![]()
MyMD Pharmaceuticals Announces Live Appearance on Cheddar News Network Today March 24
March 24, 2022
Via Business Wire
Tickers
MYMD
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|